Altamira Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

3 months ago

HAMILTON, BERMUDA, Dec. 29, 2023 (GLOBE NEWSWIRE) -- HAMILTON, BERMUDA, Dec. 29, 2023 -- Altamira Therapeutics Ltd. ("Altamira" or the…

iZafe Group Receives Confirmed Order for 1,000 Dosell Units to the Netherlands

3 months ago

STOCKHOLM, SWEDEN / ACCESSWIRE / December 29, 2023 / iZafe Group (STO:IZAFE-B) iZafe Group AB ("iZafe Group") announces today that…

INSP Shareholder Alert: Robbins LLP Reminds Investors of Class Action Filed Against Inspire Medical Systems, Inc.

3 months ago

SAN DIEGO--(BUSINESS WIRE)--$INSP #InspireMedicalSystemsInc--Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons or…

VerityXR Strengthens Leadership Team with Appointment of Dr. Doug Nelson, PhD as Chief Architect and Engineer

3 months ago

CHICAGO, IL / ACCESSWIRE / December 28, 2023 / VerityXR, a trailblazer in Extended Reality (XR) healthcare technologies, is excited…

Establishment Labs to Present at the 42nd Annual J.P. Morgan Healthcare Conference

3 months ago

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness,…

NeoGenomics to Appeal Ruling

3 months ago

FORT MYERS, FL / ACCESSWIRE / December 28, 2023 / NeoGenomics, Inc. (NASDAQ:NEO) (the "Company"), a leading oncology testing services…

BriaCell Reports 71% Central Nervous System Response Rate in Advanced Breast Cancer Patients

3 months ago

71% intracranial objective response rate (iORR) in BriaCell patients with Central Nervous System (CNS) metastases support clinical efficacy of Bria-IMT™,…

SeaStar Medical Updates Subject Enrollment in its Pivotal Trial with the Selective Cytopheretic Device in Adults with Acute Kidney Injury

3 months ago

DENVER, Dec. 28, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions…

MIMEDX Announces Conversion of Outstanding Series B Convertible Preferred Stock to Common Stock

3 months ago

MARIETTA, Ga., Dec. 28, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that…

Bluejay Diagnostics Announces Pricing of $3.5 Million Public Offering

3 months ago

ACTON, Mass., Dec. 28, 2023 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology…